AHA Scientific Sessions 2008
Major new trials reported at the American Heart Association 2008 Scientific Sessions, held in New Orleans on November 8th – 12th, showed encouraging results for rosuvastatin in the primary prevention of cardiovascular events, while exercise in heart failure patients produced modest health benefits.